Dow Down 0.41% Nasdaq Down 0.41%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS
10.41 Up 0.20(1.91%) 2:46PM EDT - Nasdaq Real Time Price
Prev Close:10.21
Open:10.29
Bid:10.38 x 1700
Ask:10.39 x 5300
1y Target Est:10.43
Beta:2.13255
Earnings Date:Nov 1 - Nov 7 (Est.)
Day's Range:10.27 - 10.45
52wk Range:4.37 - 10.85
Volume:2,689,333
Avg Vol (3m):5,033,930
Market Cap:2.01B
P/E (ttm):N/A
EPS (ttm):-0.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARIAUp 1.91%2.01B
PFEDown 0.60%211.69B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.62
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.08
Quarterly EPS Est (Sep-16) :-0.20
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-4.27

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of drugs for cancer patients in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback